Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease

Thyroid

Volumn 9, Issue 8, 1999, Pages 775-779

  Nakazato, Naoki ^a   Yoshida, Katsumi ^a,b   Mori, Kouki ^a   Kiso, Yoshinori ^a   Sayama, Noriyo ^a   Tani, Jun Ichi ^a   Nakagawa, Yoshinori ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; LIOTHYRONINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; DRUG EFFICACY; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0032841649     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.775     Document Type: Article

References (25)

1. Graham GD, Burman KD 1986 Radioiodine treatment of Graves' disease. An assessment of its potential risks. Ann Intern Med 105:900-905.
2. Farrar JJ, Toft AD 1991 Iodine-131 treatment of hyperthyroidism: Current issues. Clin Endocrinol 35:207-212.
3. Kendall-Taylor P, Keir MJ, Ross WM 1984 Ablative radioiodine therapy for hyperthyroidism: Long-term follow-up study. Br Med J 289:361-363.
4. McGregor AM, Petersen MM, Capiferri R, Evered DC, Smith BR, Hall R 1979 Effects of radioiodine on thyrotropin binding inhibiting immunoglobulins in Graves' disease. Clin Endocrinol 11:437-444.
5. Atkinson S, McGregor AM, Kendall-Taylor P, Peterson MM, Smith BR 1982 Effect of radioiodine on stimulatory activity of Graves' immunoglobulins. Clin Endocrinol 16:537-543.
6. 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease. J Clin Endocrinol Metab 62:773-777.
7. Gamstedt A, Karlsson A 1991 Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: Thyroid autoantibody responses and outcome of therapy. J Clin Endocrinol Metab 73:125-131.
8. Aizawa Y, Yoshida K, Kaise N, Kaise K, Fukazawa H, Kiso Y, Sayama N, Hori H, Abe K 1997 The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: Prevalence, mechanism, and prognosis. Clin Endocrinol 46:1-5.
9. 131I treatment for Graves' disease. Clin Endocrinol 48:17-22.
10. Shewring, G., Smith BR 1982 An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol 17:409-417.
11. Aizawa Y, Yoshida K, Kaise N, Kaise K, Fukazawa H, Kiso Y, Mori K, Sayama N, Kikuchi K, Abe K 1995 Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease. Clin Endocrinol 42:517-522.
12. Yoshida K, Aizawa Y, Kaise N, Fukazawa H, Kiso Y, Sayama N, Mori K, Hori H, Abe K 1996 Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: Retrospective clinical survey. J Endocrinol Invest 19:682-686.
13. Uller RP, Herle JV 1978 Effect of therapy on serum thyroglobulin levels in patients with Graves' disease. J Clin Endocrinol Metab 46:747-755.
14. McGregor A, McLachlan SM, Smith BR, Hall, R 1979 Effect of irradiation on thyroid-autoantibody production. Lancet 2:442-444.
15. DeGroot LJ 1997 Radioiodine and the immune system. Thyroid 7:259-264.
16. Cooper DS 1984 Antithyroid drugs. N Engl J Med 311:1353-1362.
17. McGregor AM, Ibbertson HK, Smith BR, Hall R 1980 Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis. Br Med J 281:968-969.
18. Kendall-Taylor P 1984 Are antithyroid drugs immunosuppressive? Br Med J 289:361-363.
19. McGregor AM, Petersen MM, McLachlan SM, Rooke P, Smith BR, Hall R 1980 Carbimazole and the autoimmune response in Graves' disease. N Engl J Med 303:302-307.
20. Weetman AP, McGregor AM, Hall R 1983 Methimazole inhibits thyroid autoantibody production by an action on accesory cells. Clin Immunol Immunopathol 28:39-45.
21. Saji M, Moriarty J, Ban T, Singer DS, Kohn LD 1992 Major histocompatibility complex class I gene expression in rat thyroid cells is regulated by hormones, methimazole, and iodide as well as interferon. J Clin Endocrinol Metab 75:871-878.
22. Montani V, Shong M, Taniguchi SI, Suzuki K, Giuliani C, Napolitano G, Saito J, Saji M, Fiorentino B, Reimold AM, Singer DS, Kohn LD 1998 Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: Opposite effects of interferon and methimazole. Endocrinology 139:290-302.
23. Botazzo GF, Pujol-Burrell R, Hanafusa T, Feldmann M 1983 Role of aberrant HLA-DR expression and antigen presentation in induction of thyroid autoimmunity. Lancet 2:1115-1119.
24. 131I therapy for Graves' disease. N Engl J Med 311:426-432.
25. Marcocci C, Gianchecchi D, Masini I, Golia F, Ceccarelli C, Bracci E, Fenzi GF, Pinchera A 1990 A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 13:513-520.